Safety and efficacy of ribociclib and letrozole in advanced breast cancer – the MONALEESA-2 trial VJOncology 2:49 7 years ago 2 476 Скачать Далее
MONALEESA-2: improved OS seen in HR+ advanced breast cancer treated with ribociclib + letrozole VJOncology 1:19 2 years ago 317 Скачать Далее
Early RIBECCA results: ribociclib with letrozole for metastatic breast cancer VJOncology 1:40 5 years ago 973 Скачать Далее
MONALEESA-2: ribociclib + letrozole in pts with de novo metastatic disease and late recurrence VJOncology 1:29 1 year ago 603 Скачать Далее
ESMO 2016: Press brief on the MONALEESA-2 clinical trial on breast cancer VJOncology 9:39 7 years ago 1 158 Скачать Далее
Updated Results of the MONALEESA-2 Trial in HR+/HER2- Breast Cancer Targeted Oncology 2:26 7 years ago 204 Скачать Далее
Dr. Hortobagyi on MONALEESA-2 Trial Results in Breast Cancer OncLive 2:40 7 years ago 416 Скачать Далее
RIBECCA: ribociclib, a CDK4/6 inhibitor in ER+ breast cancer VJOncology 1:26 3 years ago 597 Скачать Далее
Overall survival results from MONALEESA-2: Endocrine therapy and ribociclib in HR positive and H... ecancer 13:54 2 years ago 659 Скачать Далее
Dr. Burris on Updated MONALEESA-2 Trial Results for HR+ Breast Cancer OncLive 2:35 7 years ago 234 Скачать Далее
NEW TREATMENT FOR ADVANCED BREAST CANCER: RIBOCICLIB Ivanhoe Web 1:36 7 years ago 1 259 Скачать Далее
Overall survival results from MONALEESA-3 study on ribociclib plus fulvestrant in advanced breas... ecancer 3:09 4 years ago 209 Скачать Далее
RIGHT Choice: ribociclib + ET vs combo chemo in aggressive HR+/HER2− advanced breast cancer VJOncology 2:46 1 year ago 1 642 Скачать Далее
Frontline endocrine therapies and ribociclib in early stage HR+ HER2- breast cancer VJOncology 1:39 1 year ago 158 Скачать Далее
Efficacy and Quality of Life Outcomes With Ribociclib Plus Letrozole vs Letrozole Alone for MBC PracticeUpdate 3:38 2 years ago 579 Скачать Далее
